David A. Siegel Guardant Health, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 770,800 shares of GH stock, worth $22 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
770,800
Previous 793,900
2.91%
Holding current value
$22 Million
Previous $16.4 Million
35.91%
% of portfolio
0.05%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding GH
# of Institutions
328Shares Held
115MCall Options Held
680KPut Options Held
1.67M-
Vanguard Group Inc Valley Forge, PA11.6MShares$333 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$321 Million0.01% of portfolio
-
Baillie Gifford & CO5.87MShares$168 Million0.1% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$129 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$128 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.92B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...